Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950136-04-002024
Filing Date
2004-06-25
Accepted
2004-06-25 11:36:26
Documents
1
Group Members
APOTEX HOLDINGS INC.SHERFAM INC.SHERMAN DELAWARE, INC.SHERMAN HOLDINGS INC.SHERMCO INC.SHERMFIN INC.THE BERNARD SHERMAN 2000 TRUST

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE 13D file001.txt SC 13D/A 29578
  Complete submission text file 0000950136-04-002024.txt   31831
Mailing Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519
Business Address 2 QUAKER RD BOX 2900 POMONA NY 10970-0519 8453621100
BARR PHARMACEUTICALS INC (Subject) CIK: 0000010081 (see all company filings)

EIN.: 221927534 | State of Incorp.: NY | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-42092 | Film No.: 04881196
SIC: 2834 Pharmaceutical Preparations

Mailing Address 150 SIGNET DR WESTON ONTARIO CANADA M9L 1T9 A6
Business Address HARTMAN & CRAVEN LLP 460 PARK AVENUE NEW YORK NY 10022 4167499300
SHERMAN BERNARD C (Filed by) CIK: 0000936837 (see all company filings)